Company Filing History:
2 out of 4,455 
2 out of 15,475 
Years Active: 2022-2025
Title: The Innovative Contributions of Kyle Steven Niessen
Introduction
Kyle Steven Niessen is a notable inventor based in Edina, MN (US). He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 2 patents, Niessen's work focuses on the development of antibodies that target specific integrins involved in cancer progression.
Latest Patents
Niessen's latest patents include a method of treating cancer using anti-AV8 antibodies. This invention provides antibodies and antigen-binding fragments that specifically bind to αvβ8 integrin. The invention encompasses various uses and associated methods for utilizing these antibodies effectively. Another significant patent is for anti-AVB8 antibodies and compositions, which also specifically bind to αvβ8 integrin, including their uses and methods of application.
Career Highlights
Throughout his career, Niessen has worked with prominent organizations such as Pfizer Corporation and the University of California. His experience in these institutions has contributed to his expertise in the field of biomedical research and innovation.
Collaborations
Some of his notable coworkers include Dharmaraj Samuel and Charles Ray Holst. Their collaborative efforts have likely enhanced the research and development of Niessen's innovative projects.
Conclusion
Kyle Steven Niessen's contributions to cancer treatment through his patents demonstrate his commitment to advancing medical science. His work continues to inspire future innovations in the field.